Skip to main content
. Author manuscript; available in PMC: 2019 Dec 9.
Published in final edited form as: J Clin Pathol. 2018 Sep 18;71(12):1108–1115. doi: 10.1136/jclinpath-2018-205396

Figure 1. Assay Performance.

Figure 1.

A) Success rate and reasons for assay failure. B) Distribution of sample types. C) Distribution of samples collection sites within the University Hospital System. D) Turn-around times three different assays used to determine EGFR mutation status, or EGFR mutation status and other alterations. EGFR Therascreen® and FoundationOne® data were collected from 2014-2016. Data for the in-house Focus Panel, which includes both the Oncomine™ Focus Assay and the expanded Solid Tumor Focus Assay, were collected from 2016-2018. n = 302 for all pie charts.